{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:19:27Z","timestamp":1783448367819,"version":"3.55.0"},"reference-count":46,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":257,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Using a large patient series, we aimed to evaluate, in a high-responder population, the effect of triggering oocyte maturation with human choriogonadotropin (hCG) or with a gonadotropin-releasing hormone agonist (GnRHa). We analyzed data from 683 intended fresh embryo transfer cycles (ETCs) and 534 frozen-thawed embryo transfer (FET) cycles. The rates of ovarian hyperstimulation syndrome (OHSS), and the embryological, clinical, and newborn outcomes were compared. Considering the type of oocyte maturation trigger and embryo destination, cycles were divided into five groups. Cycles using an hCG-trigger, with progesterone luteal support, had fresh embryo transfer or embryo freeze-all (FA). Cycles using GnRHa\/agonist-trigger, with hCG, estrogen, and progesterone luteal support, had fresh embryo transfer or embryo FA. The fifth group consisted of agonist-trigger cycles, without luteal support, that underwent embryo FA. Severe OHSS only occurred in fresh ETC, with the agonist-trigger evidencing a non-significantly lower rate. The FA groups evidenced higher numbers of retrieved oocytes and blastocyst rates. In fresh ETC, the Ag-fresh-hCG group evidenced higher implantation and clinical pregnancy rates. No differences were observed in clinical outcomes after FET, but cumulative clinical outcomes showed higher clinical pregnancy and newborn rates in the Ag-fresh-hCG group. After multivariable logistic regression analysis, these differences were not observed. The present results thus suggest that, in high-responders, the use of a GnRHa-trigger with luteal hCG in a fresh ETC presents similar outcomes relative to the use of an hCG-trigger. Data also suggest that FA should be applied to all suspected OHSS cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay summary<\/jats:title>\n                    <jats:p>Ovarian hyperstimulation syndrome (OHSS) is a complication of medically assisted reproduction treatments that may require hospitalization. In the presence of high risk to develop OHSS, embryo transfer can be canceled and embryos frozen to be used in a later cycle. Alternatively, a newer drug, an agonist, can be used for egg trigger in association with endometrium special preparation. Some characteristics make women more susceptible to develop OHSS. In this group of patients, we observed that the use of an agonist as egg trigger did not decrease pregnancy outcomes and that the option of freezing all embryos followed by embryo transfer in a later cycle abolished development of OHSS with hospitalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/raf-24-0105","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:09:42Z","timestamp":1759838982000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-13","source":"Crossref","is-referenced-by-count":0,"title":["Oocyte maturation triggers in high-responders: a report on 1,217 consecutive cycles"],"prefix":"10.1530","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7280-9015","authenticated-orcid":true,"given":"Maria","family":"Gon\u00e7alves","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-6400","authenticated-orcid":true,"given":"Mariana","family":"Cunha","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Teixeira da Silva","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3799-3232","authenticated-orcid":true,"given":"Joaquina","family":"Silva","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0703-7119","authenticated-orcid":true,"given":"Paulo","family":"Viana","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Oliveira","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-5853","authenticated-orcid":true,"given":"Margarida Fonseca","family":"Cardoso","sequence":"additional","affiliation":[{"name":"4"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Barros","sequence":"additional","affiliation":[{"name":"3"},{"name":"6"},{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-3290","authenticated-orcid":true,"given":"M\u00e1rio","family":"Sousa","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2026070714092071200_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.826411","article-title":"Reproductive outcome after GnRH agonist triggering with co-administration of 1500 IU hCG on the day of oocyte retrieval in high responders: a long-term retrospective cohort study","volume":"13","author":"Abdulkhalikova","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026070714092071200_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2026070714092071200_bib3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"Alpha scientists in reproductive medicine and ESHRE special interest group of embryology. The istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","author":"Balaban","year":"2011","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/03009734.2020.1736696","article-title":"Gonadotropin-releasing hormone agonist for ovulation trigger \u2013 OHSS prevention and use of modified luteal phase support for fresh embryo transfer","volume":"125","author":"Castillo","year":"2020","journal-title":"Upsala J Med Sci"},{"key":"2026070714092071200_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14647273.2016.1217432","article-title":"GnRH agonist trigger with intensive luteal phase support vs human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome","volume":"19","author":"Christopoulos","year":"2016","journal-title":"Hum Fertil"},{"key":"2026070714092071200_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/humupd\/dmg005","article-title":"Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)","volume":"9","author":"Delvigne","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2026070714092071200_bib7","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/der251","article-title":"An OHSS-free clinic by segmentation of IVF treatment","volume":"26","author":"Devroey","year":"2011","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2022.102301","article-title":"Treatment algorithms for high responders: what we can learn from randomized controlled trials, real-world data and models","volume":"86","author":"Drakopoulos","year":"2023","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026070714092071200_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10815-023-02757-4","article-title":"The HERA (Hyper-response risk assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization","volume":"40","author":"Feferkorn","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"2026070714092071200_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3109\/09513590.2015.1025379","article-title":"Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome","volume":"31","author":"Fusi","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2026070714092071200_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/19396368.2015.1089607","article-title":"The continuum of high ovarian response: a rational approach to the management of high responder patient subgroups","volume":"61","author":"Gat","year":"2015","journal-title":"Syst Biol Reprod Med"},{"key":"2026070714092071200_bib13","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3390\/genes14112095","article-title":"Preimplantation genetic testing for genetic diseases: limits and review of current literature","volume":"14","author":"Giuliano","year":"2023","journal-title":"Genes"},{"key":"2026070714092071200_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/1008-682X.172827","article-title":"Y-chromosome microdeletions in nonobstructive azoospermia and severe oligozoospermia","volume":"19","author":"Gon\u00e7alves","year":"2017","journal-title":"Asian J Androl"},{"key":"2026070714092071200_bib15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714092071200_bib16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.fertnstert.2009.07.1662","article-title":"The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome","volume":"94","author":"Grossman","year":"2010","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib17","first-page":"15","article-title":"GnRHa trigger-the story of the ugly duckling","volume":"4","author":"Humaidan","year":"2023","journal-title":"F S Rep"},{"key":"2026070714092071200_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.fertnstert.2008.12.042","article-title":"1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study","volume":"93","author":"Humaidan","year":"2010","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"2026070714092071200_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rbmo.2011.11.001","article-title":"The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives","volume":"24","author":"Humaidan","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"2026070714092071200_bib22","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/humrep\/det249","article-title":"GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib23","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/humrep\/det287","article-title":"GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients","volume":"28","author":"Humaidan","year":"2013","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib24","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","article-title":"The novel POSEIDON stratification of 'low prognosis patients in assisted reproductive technology' and its proposed marker of successful outcome","volume":"5","author":"Humaidan","year":"2016","journal-title":"F1000Res"},{"key":"2026070714092071200_bib25","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/humrep\/dem270","article-title":"Are GnRH antagonists comparable to agonists for use in IVF?","volume":"22","author":"Huirne","year":"2007","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib26","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/humrep\/det304","article-title":"Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study","volume":"28","author":"Iliodromiti","year":"2013","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0015-0282(01)02893-X","article-title":"Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders","volume":"76","author":"Kligman","year":"2001","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.rbmo.2010.06.031","article-title":"LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?","volume":"21","author":"Kol","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2026070714092071200_bib29","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/humrep\/dei150","article-title":"A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists","volume":"20","author":"Kolibianakis","year":"2005","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/andr.13514","article-title":"EAA\/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state of the art 2023","volume":"12","author":"Krausz","year":"2024","journal-title":"Andrology"},{"key":"2026070714092071200_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rbmo.2017.09.010","article-title":"Clinical outcomes after preimplantation genetic diagnosis of patients with Corino de Andrade disease (familial amyloid polyneuropathy)","volume":"36","author":"Lopes","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2026070714092071200_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.2047-2927.2014.00231.x","article-title":"Treatment by testicular sperm extraction and intracytoplasmic sperm injection of 65 azoospermic patients with non-mosaic Klinefelter syndrome with birth of 17 healthy children","volume":"2","author":"Madureira","year":"2014","journal-title":"Andrology"},{"key":"2026070714092071200_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.834627","article-title":"Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients","volume":"13","author":"Martazanova","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026070714092071200_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0032-1311525","article-title":"To transfer fresh or thawed embryos?","volume":"30","author":"Pinborg","year":"2012","journal-title":"Semin Reprod Med"},{"key":"2026070714092071200_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7827-7-5","article-title":"Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes","volume":"7","author":"Pinto","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"2026070714092071200_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2023.11.013","article-title":"Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"121","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2024","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib37","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/humrep\/der333","article-title":"Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates","volume":"26","author":"Radesic","year":"2011","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib38","volume-title":"Human Chromosome Preparation. Essential Techniques","author":"Rooney","year":"1997"},{"key":"2026070714092071200_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2012.09.044","article-title":"Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles","volume":"99","author":"Shapiro","year":"2013","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/oxfordjournals.humrep.a137223","article-title":"Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist\/HMG superovulation for in-vitro fertilization","volume":"5","author":"Smitz","year":"1990","journal-title":"Hum Reprod"},{"key":"2026070714092071200_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12958-015-0067-3","article-title":"Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles","volume":"13","author":"Sousa","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"2026070714092071200_bib42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/09513590.2017.1318275","article-title":"GnRH-agonist triggering for final oocyte maturation in GnRH-antagonist IVF cycles induces decreased LH pulse rate and amplitude in early luteal phase: a possible luteolysis mechanism","volume":"33","author":"Tannus","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2026070714092071200_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0015-0282(16)57853-4","article-title":"Key elements of a highly efficient intracytoplasmic sperm injection technique: Ca2+ fluxes and oocyte cytoplasmic dislocation","volume":"64","author":"Tesarik","year":"1995","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib44","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2012.07.1058","article-title":"Pregnancy loss after frozen-embryo transfer-a comparison of three protocols","volume":"98","author":"Tom\u00e1s","year":"2012","journal-title":"Fertil Steril"},{"key":"2026070714092071200_bib45","volume-title":"WHO Laboratory Manual for the Examination and Processing of Human Semen","author":"WHO","year":"2021","edition":"6th edn"},{"key":"2026070714092071200_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"}],"container-title":["Reproduction and Fertility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/raf.bioscientifica.com\/view\/journals\/raf\/6\/4\/RAF-24-0105.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/raf.bioscientifica.com\/downloadpdf\/journals\/raf\/6\/4\/RAF-24-0105.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-24-0105\/508642\/raf-24-0105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article-pdf\/doi\/10.1530\/RAF-24-0105\/508642\/raf-24-0105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:09:32Z","timestamp":1783447772000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/raf\/article\/6\/4\/e240105\/75984\/Oocyte-maturation-triggers-in-high-responders-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/raf-24-0105","relation":{},"ISSN":["2633-8386"],"issn-type":[{"value":"2633-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"e240105"}}